Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 6
1992 20
1993 18
1994 19
1995 21
1996 24
1997 16
1998 20
1999 18
2000 33
2001 21
2002 27
2003 23
2004 15
2005 20
2006 13
2007 19
2008 21
2009 22
2010 23
2011 17
2012 24
2013 25
2014 21
2015 22
2016 16
2017 19
2018 21
2019 18
2020 14
2021 18
2022 30
2023 25
2024 13

Search Results

626 results

Results by year

Filters applied: . Clear all
Page 1
Neurofibromatosis type 2.
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Asthagiri AR, et al. Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Lancet. 2009. PMID: 19476995 Free PMC article. Review.
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
Neurofibromatosis type 2.
Slattery WH. Slattery WH. Otolaryngol Clin North Am. 2015 Jun;48(3):443-60. doi: 10.1016/j.otc.2015.02.005. Otolaryngol Clin North Am. 2015. PMID: 26043141 Review.
Neurofibromatosis type 2.
Evans DG. Evans DG. Handb Clin Neurol. 2015;132:87-96. doi: 10.1016/B978-0-444-62702-5.00005-6. Handb Clin Neurol. 2015. PMID: 26564072 Review.
Multifocality in neurofibromatosis type 2.
Evans DG, Stivaros SM. Evans DG, et al. Neuro Oncol. 2015 Apr;17(4):481-2. doi: 10.1093/neuonc/nou338. Epub 2014 Dec 23. Neuro Oncol. 2015. PMID: 25537020 Free PMC article. No abstract available.
Neurofibromatosis type 2 and related disorders.
Halliday D, Parry A, Evans DG. Halliday D, et al. Curr Opin Oncol. 2019 Nov;31(6):562-567. doi: 10.1097/CCO.0000000000000579. Curr Opin Oncol. 2019. PMID: 31425178 Review.
Neurofibromatosis type 2.
Evans DG, Sainio M, Baser ME. Evans DG, et al. J Med Genet. 2000 Dec;37(12):897-904. doi: 10.1136/jmg.37.12.897. J Med Genet. 2000. PMID: 11106352 Free PMC article. Review.
Neurofibromatosis type 2.
Thomas G, Mérel P, Sanson M, Hoang-Xuan K, Zucman J, Desmaze C, Melot T, Aurias A, Delattre O. Thomas G, et al. Eur J Cancer. 1994;30A(13):1981-7. doi: 10.1016/0959-8049(94)00390-q. Eur J Cancer. 1994. PMID: 7734211 Review. No abstract available.
626 results